Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilfactin continuous infusion in major surgery for severe von Willebrand disease
2007-004116-32Phase 3Completed
- Sponsor
- LFB Group
- Start
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of von Willebrand factor human in von Willebrand disease (VWD), sponsored by LFB Group. Primary endpoint: Overall haemostatic efficacy during and after surgery. Started Mar 2009; status: completed.
02
Drugs
von Willebrand factor human
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2007-004116-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004116-32.